Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.

Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct; 10(10):1475-80.

View in: PubMed

subject areas

Aged
Carcinoma, Non-Small-Cell Lung
Chemoradiotherapy, Adjuvant
Cohort Studies
Disease-Free Survival
Female
Humans
Lung Neoplasms
Male
Neoplasm Staging
Retrospective Studies
Survival Analysis
Treatment Outcome

authors with profiles

Michael Liptay
Philip Bonomi
Mary Jo Fidler
Marta Batus